These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 14455770)

  • 1. [Indication of chondroitin sulfate in eye diseases].
    KIDA S; FUJITA N; KITA Y
    Nihon Ganka Kiyo; 1961 Sep; 12():720-8. PubMed ID: 14455770
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of disturbances of smell by means of chondroitin sulfate].
    KUBO M; SHIDA A; KISHI K
    Jibiinkoka; 1961 Feb; 33():131-3. PubMed ID: 13754790
    [No Abstract]   [Full Text] [Related]  

  • 3. [An experience in the use of chondroitin sulfate in nervous deafness and traumatic deafness].
    YASUMOTO Y
    Jibiinkoka; 1961 Jun; 33():561-7. PubMed ID: 13787259
    [No Abstract]   [Full Text] [Related]  

  • 4. [A preliminary report on effect of chondroitin sulfate to diabetic retinopathia].
    MIYAMURA A; KANEKO K; NISHIZUKA M; NAKAI Y
    Nihon Ganka Kiyo; 1961 Dec; 12():1073-5. PubMed ID: 14474820
    [No Abstract]   [Full Text] [Related]  

  • 5. Epitope-specific changes in chondroitin sulfate/dermatan sulfate proteoglycans as markers in the lymphopoietic and granulopoietic compartments of developing bursae of Fabricius.
    Sorrell JM; Lintala AM; Mahmoodian F; Caterson B
    J Immunol; 1988 Jun; 140(12):4263-70. PubMed ID: 2453574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of oxygen therapy in some eye diseases].
    OKHRIMENKO VE
    Oftalmol Zh; 1962; 17():228-31. PubMed ID: 14481556
    [No Abstract]   [Full Text] [Related]  

  • 7. [ACTH in some eye diseases].
    KLYKOVA AL; KUZINA AN
    Vestn Oftalmol; 1959; 72():49-50. PubMed ID: 14410035
    [No Abstract]   [Full Text] [Related]  

  • 8. [On oral prednisolone therapy of eye diseases].
    PALICH-SZANTO O
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1961; 64():230-3. PubMed ID: 14483334
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vitamin B12 in various eye diseases].
    MARTYNOVSKAIA VI
    Vestn Oftalmol; 1961; 74():31-3. PubMed ID: 13767618
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of chondroitin sulfate bioactivity in hippocampal neurones and the astrocyte cell line U373: influence of position of sulfate groups and charge density.
    Rapp A; Brandl N; Volpi N; Huettinger M
    Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):37-43. PubMed ID: 15667594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the subconjunctival use of intermedin in some eye diseases].
    PINDICH DT
    Vestn Oftalmol; 1961; 74():66-70. PubMed ID: 14486718
    [No Abstract]   [Full Text] [Related]  

  • 12. [Systemic administration of corticosteroids for eye diseases].
    KUBOTA Y
    Nippon Ganka Gakkai Zasshi; 1961 Dec; 65():2403-10. PubMed ID: 14460128
    [No Abstract]   [Full Text] [Related]  

  • 13. Nitric oxide products degrade chondroitin sulfates.
    Hassan MS; Mileva MM; Dweck HS; Rosenfeld L
    Nitric Oxide; 1998; 2(5):360-5. PubMed ID: 10100491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of age upon sulfate-S35 fixation of chondroitin sulfate in cartilage and bone of the normal white rats and S35-autoradiographic study of these tissues.
    TAKEMITSU Y
    Kyushu J Med Sci; 1961 Oct; 12():251-81. PubMed ID: 13919212
    [No Abstract]   [Full Text] [Related]  

  • 15. [Penicillin in ophthalmology].
    WEEKERS R
    Rev Med Liege; 1947 Sep; 2(17):481-4. PubMed ID: 18920312
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the treatment of gastro-duodenal diseases with sodium chondroitin sulfate].
    PIROLA P; POZZI G
    Gazz Med Ital; 1963 May; 122():141-9. PubMed ID: 13943771
    [No Abstract]   [Full Text] [Related]  

  • 17. Diuretics in ophthalmology.
    GALIN MA; DAVIDSON RA
    N Y State J Med; 1962 Sep; 62():2131-6. PubMed ID: 13896356
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of dexamethasone in eye disease.
    GORDON DM
    J Am Med Assoc; 1960 Jan; 172():311-2. PubMed ID: 13851186
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial.
    Pérez-Balbuena AL; Ochoa-Tabares JC; Belalcazar-Rey S; Urzúa-Salinas C; Saucedo-Rodríguez LR; Velasco-Ramos R; Suárez-Sánchez RG; Rodríguez-Carrizalez AD; Oregón-Miranda AA
    BMC Ophthalmol; 2016 Sep; 16(1):164. PubMed ID: 27645318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A NEW DYSOSTOSIS WITH URINARY ELIMINATION OF CHONDROITIN SULFATE B].
    MAROTEAUX P; LEVEQUE B; MARIE J; LAMY M
    Presse Med (1893); 1963 Sep; 71():1849-52. PubMed ID: 14091597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.